Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
US Market

Pharmagreen Biotech (PHBI) Stock Price & Analysis

47 Followers

PHBI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume2.72M
Average Volume (3M)N/A
Market Cap
$597.28K
Enterprise Value$906.53K
Total Cash (Recent Filing)$743.00
Total Debt (Recent Filing)$356.70K
Price to Earnings (P/E)
Beta-1.09
Sep 02, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding663,645,739
10 Day Avg. Volume563,020
30 Day Avg. VolumeN/A
Standard Deviation0.42
R-Squared0.05
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.23
Price to Sales (P/S)177.09
Price to Cash Flow (P/CF)-66.90
P/FCF Ratio20.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue324.23
Enterprise Value/Gross Profit974.77
Enterprise Value/Ebitda-1.93
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

PHBI FAQ

What was Pharmagreen Biotech Inc.’s price range in the past 12 months?
Currently, no data Available
What is Pharmagreen Biotech Inc.’s market cap?
Currently, no data Available
When is Pharmagreen Biotech Inc.’s upcoming earnings report date?
Pharmagreen Biotech Inc.’s upcoming earnings report date is Sep 02, 2024 which is in 36 days.
    How were Pharmagreen Biotech Inc.’s earnings last quarter?
    Pharmagreen Biotech Inc. released its earnings results on May 21, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
      Is Pharmagreen Biotech Inc. overvalued?
      According to Wall Street analysts Pharmagreen Biotech Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Pharmagreen Biotech Inc. pay dividends?
        Pharmagreen Biotech Inc. does not currently pay dividends.
        What is Pharmagreen Biotech Inc.’s EPS estimate?
        Pharmagreen Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Pharmagreen Biotech Inc. have?
        Pharmagreen Biotech Inc. has 663,645,750 shares outstanding.
          What happened to Pharmagreen Biotech Inc.’s price movement after its last earnings report?
          Pharmagreen Biotech Inc. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Pharmagreen Biotech Inc.?
            Currently, no hedge funds are holding shares in PHBI
            ---

            Pharmagreen Biotech Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            Trailing 12-Months
            Asset Growth
            -36.31%
            Trailing 12-Months

            Company Description

            Pharmagreen Biotech Inc.

            Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm's products focus on manufacturing and marketing of cannabis products for medical and recreational markets. Its services include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. The company was founded on November 26, 2007 and is headquartered in Coquitlam, Canada.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Vericel
            Galectin Therapeutics
            Viveve Medical
            PacificHealth Laboratories
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis